• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗毒性是否得到准确报告?

Is cancer treatment toxicity accurately reported?

作者信息

Parliament M B, Danjoux C E, Clayton T

出版信息

Int J Radiat Oncol Biol Phys. 1985 Mar;11(3):603-8. doi: 10.1016/0360-3016(85)90195-6.

DOI:10.1016/0360-3016(85)90195-6
PMID:3972669
Abstract

To assess current documentation of treatment-related toxicity, 46 out-patients attending the Ottawa Civic Hospital Cancer Clinic were randomly selected. Physician's charting of toxicities was compared to patient's perception of toxicity, as recorded on a brief questionnaire. As a group, patients reported significantly more toxicities than had been recorded by their physician. The greatest disparity was observed for the following categories: nausea, vomiting, alopecia, and decreased performance status. The best-documented toxicities were: skin and mucosal reactions, and urinary symptoms. To the question concerning their most bothersome symptoms, patients described nausea, vomiting, mucosal reaction, and decreased performance status as the most common. In 46% of cases, the physician's notes failed to identify the patient's worst symptom. From our study; toxicity is probably under-reported, and unrecognized by oncologists. A self-administered questionnaire appears to be a better way of accurately identifying and reporting treatment toxicities, when compared to the oncologist's evaluation, as recorded in the patient's permanent record.

摘要

为评估当前与治疗相关毒性的记录情况,从渥太华市民医院癌症诊所就诊的46名门诊患者中随机选取。将医生对毒性的记录与患者在一份简短问卷中记录的对毒性的感知进行比较。总体而言,患者报告的毒性显著多于医生记录的毒性。在以下类别中观察到最大差异:恶心、呕吐、脱发和身体状况下降。记录最完善的毒性是:皮肤和黏膜反应以及泌尿系统症状。对于关于他们最困扰症状的问题,患者将恶心、呕吐、黏膜反应和身体状况下降描述为最常见的。在46%的病例中,医生的记录未能识别出患者最严重的症状。根据我们的研究,毒性可能报告不足,且未被肿瘤学家认识到。与记录在患者永久病历中的肿瘤学家评估相比,自我管理的问卷似乎是准确识别和报告治疗毒性的更好方法。

相似文献

1
Is cancer treatment toxicity accurately reported?癌症治疗毒性是否得到准确报告?
Int J Radiat Oncol Biol Phys. 1985 Mar;11(3):603-8. doi: 10.1016/0360-3016(85)90195-6.
2
Pycnogenol may alleviate adverse effects in oncologic treatment.碧萝芷可能减轻肿瘤治疗中的不良反应。
Panminerva Med. 2008 Sep;50(3):227-34.
3
[Perceptual gap between oncologists/oncology nurses and patients in the management and impact of chemotherapy/radiotherapy-induced nausea and vomiting: French results of the GAP survey].[肿瘤学家/肿瘤护理人员与患者在化疗/放疗引起的恶心和呕吐管理及影响方面的认知差距:GAP调查的法国结果]
Bull Cancer. 2016 May;103(5):469-77. doi: 10.1016/j.bulcan.2016.02.011. Epub 2016 Mar 22.
4
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.抗癌治疗期间出现的有症状毒性:三项随机试验中患者报告和医生报告的一致性。
J Clin Oncol. 2015 Mar 10;33(8):910-5. doi: 10.1200/JCO.2014.57.9334. Epub 2015 Jan 26.
5
Patients' and physiotherapists' belief in and use of acupuncture for cancer-related symptoms.患者和物理治疗师对针灸治疗癌症相关症状的信念及使用情况。
Acupunct Med. 2017 Aug;35(4):251-258. doi: 10.1136/acupmed-2015-011007. Epub 2017 Apr 25.
6
Patient-practitioner perception gap in treatment-induced nausea and vomiting.治疗引起的恶心和呕吐方面患者与从业者的认知差距
Br J Nurs. 2016 Sep 8;25(16):S4-S11. doi: 10.12968/bjon.2016.25.S4.
7
Common toxicities of cancer chemotherapy.癌症化疗的常见毒性
Singapore Med J. 1993 Oct;34(5):418-20.
8
Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial.在一项2期癌症治疗试验期间,与临床研究人员共享患者报告的症状毒性和体能状态的可行性及临床影响。
Clin Trials. 2016 Jun;13(3):331-7. doi: 10.1177/1740774515615540. Epub 2015 Nov 4.
9
Patients' estimation of overall treatment burden: why not ask the obvious?
J Clin Oncol. 2002 Jan 1;20(1):65-72. doi: 10.1200/JCO.2002.20.1.65.
10
A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.一项评估在门诊肿瘤诊所实施化疗引起的恶心或呕吐协作性疾病治疗管理对药房影响的试点研究。
J Oncol Pharm Pract. 2019 Jun;25(4):847-854. doi: 10.1177/1078155218765629. Epub 2018 Mar 27.

引用本文的文献

1
Identification of Uncontrolled Symptoms in Cancer Patients Using Natural Language Processing.利用自然语言处理识别癌症患者的未控症状。
J Pain Symptom Manage. 2022 Apr;63(4):610-617. doi: 10.1016/j.jpainsymman.2021.10.014. Epub 2021 Nov 4.
2
Advancing the efficiency and efficacy of patient reported outcomes with multivariate computer adaptive testing.通过多变量计算机自适应测试提高患者报告结局的效率和效果。
J Am Med Inform Assoc. 2017 Sep 1;24(5):897-902. doi: 10.1093/jamia/ocx003.
3
Utilizing Multidimensional Computer Adaptive Testing to Mitigate Burden With Patient Reported Outcomes.
利用多维计算机自适应测试减轻患者报告结局带来的负担。
AMIA Annu Symp Proc. 2015 Nov 5;2015:320-8. eCollection 2015.
4
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).利益相关者对实施美国国家癌症研究所患者报告结局版通用不良事件术语标准(PRO-CTCAE)的看法。
Transl Behav Med. 2011 Mar;1(1):110-22. doi: 10.1007/s13142-011-0025-3.
5
Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993).使用 Skindex-16 和不良事件通用术语标准评估皮疹症状:汇总分析结果(N0993)。
Support Care Cancer. 2012 Aug;20(8):1729-35. doi: 10.1007/s00520-011-1266-x. Epub 2011 Sep 16.
6
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).在一项比较莫米松乳膏与安慰剂在乳腺癌放疗期间急性皮肤毒性的 III 期试验中,比较提供者评估和患者报告的结局测量:北中央癌症治疗组(N06C4)。
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):397-402. doi: 10.1016/j.ijrobp.2010.05.065. Epub 2010 Oct 1.
7
Lifting symptom burden--how far off the ground are we?减轻症状负担——我们离目标还有多远?
Support Care Cancer. 2008 Jul;16(7):757-61. doi: 10.1007/s00520-007-0401-1. Epub 2008 Feb 7.
8
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.美国国立癌症研究所资助的临床试验网络所支持的临床试验中整合患者报告结局的问题与挑战。
J Clin Oncol. 2007 Nov 10;25(32):5051-7. doi: 10.1200/JCO.2007.11.3324.
9
Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study.睾丸癌临床I期患者及医生对长期发病率的认知:一项描述性试点研究。
Support Care Cancer. 1996 Mar;4(2):118-28. doi: 10.1007/BF01845761.